OBERON URANIUM CORP. (CSE: OBRN) ("Oberon" or the "Company") is pleased to announce that Mr. Sean Webster has been appointed as a director ...

CANBERA (dpa-AFX) - CSL (CSLLY, CSL.AX) announced that the U.S. Food and Drug Administration approved ANDEMBRY (garadacimab-gxii), the only treatment targeting factor XIIa for prophylactic use ...